Skip to main content

Jeff Lagasse

By Jeff Lagasse | 12:13 pm | February 24, 2023
The money is to test a new socialization and sex education curriculum for young people with intellectual and developmental disabilities.
By Jeff Lagasse | 10:03 am | February 24, 2023
BioPlus provides a range of specialty pharmacy services for patients living with complex and chronic conditions.
By Jeff Lagasse | 04:11 pm | February 23, 2023
The insurer says it will be exiting the business in a "phased manner" over the next 18 to 24 months.
By Jeff Lagasse | 11:37 am | February 23, 2023
With the restraining order in force, the move has been placed on hold until the legal matter is resolved.
By Jeff Lagasse | 03:46 pm | February 22, 2023
The median price for shoulder arthroscopy was 1.68 times higher at facilities within networks compared with independent hospitals.
By Jeff Lagasse | 10:58 am | February 22, 2023
This year, Medicare Advantage enrollment grew by just 1.5 million, below the pace set in previous years.
By Jeff Lagasse | 12:19 pm | February 21, 2023
MA plans have adopted more restrictive criteria commonly used by commercial health insurance carriers, found consulting firm Crowe.
By Jeff Lagasse | 03:50 pm | February 20, 2023
Patients in such models were 18% less likely to be admitted to the hospital and had a 9% lower 30-day readmission rate.
By Jeff Lagasse | 12:32 pm | February 20, 2023
On April 1, states can begin disenrolling Medicaid enrollees for the first time since March 2020.
By Jeff Lagasse | 03:22 pm | February 17, 2023
Moderna says it "remains committed" to ensuring access to the vaccines regardless of ability to pay.